Background/aims: Eyelid retraction in thyroid orbitopathy is traditionally managed with staged surgery after orbital decompression. We review the benefit of concurrent inferior retractor recession at the time of orbital decompression when closing a swinging-eyelid flap.

Methods: A retrospective, comparative, non-randomised clinical audit of 34 eyes of 22 patients with thyroid orbitopathy over a 3-year period was carried out. Patients were divided into a combined orbital decompression and inferior retractor recession (with lateral horn release) group (RG, n=13) and an orbital decompression non-recession group (NRG, n=21). Groups were matched for age, walls decompressed, volume of intraconal fat excised and improvement in exophthalmometry. Surgery involved one to three wall decompressions and intraconal fat excision via a swinging eyelid and transcaruncular approach. We report outcomes at 6 months based on postoperative standard photographs. Lower eyelid height, inferior scleral show and lower eyelid lateral flare were recorded by two blinded, independent assessors.

Results: The RG achieved a greater improvement in lower eyelid elevation (1.8 ± 0.8 mm) compared to the NRG (1.1 ± 0.8 mm) (p=0.042). The RG (58%) and NRG (40%) had improvement of lower lid lateral flare. Mean scleral show improved in both the RG (1.3 mm) and NRG (0.9 mm). No lower eyelid complications occurred.

Conclusion: Combining orbital decompression with concurrent inferior retractor recession at the time of swinging-eyelid flap closure is safe and improves lower lid height postoperatively compared to decompression alone.

Download full-text PDF

Source
http://dx.doi.org/10.1136/bjophthalmol-2011-300698DOI Listing

Publication Analysis

Top Keywords

orbital decompression
24
lower eyelid
24
thyroid orbitopathy
12
inferior retractor
12
retractor recession
12
combined orbital
8
lower
8
eyelid
8
eyelid retraction
8
retraction thyroid
8

Similar Publications

Traumatic optic neuropathy (TON) is a rare condition resulting from damage to the optic nerve due to craniofacial trauma. It can present as direct or indirect injuries, with mechanisms ranging from mechanical disruption by fractures in direct TON to transmitted forces causing shearing and ischemia in indirect TON. These injuries often lead to significant visual impairment or complete vision loss, requiring timely diagnosis and intervention.

View Article and Find Full Text PDF

Background: To report the presenting clinical, serological and treatment profiles of 1439 patients with thyroid eye disease (TED) from a tertiary centre in Hong Kong.

Study Populations: Consecutive patients with TED presented to the Thyroid Eye Clinic (TEC), the Chinese University of Hong Kong between 2014 and 2023.

Methods: Prospective cohort and masked review of medical records and orbital images.

View Article and Find Full Text PDF

Atypical lacrimal sac mucoceles.

Orbit

January 2025

Govindram Seksaria Institute of Dacryology, L.V. Prasad Eye Institute, Hyderabad, India.

Purpose: To report the clinical features and operative findings of a series of patients with lacrimal sac mucoceles extending above the anatomic level of the medial canthal tendon (MCT).

Methods: A retrospective chart review of all patients presenting with lacrimal sac mucocele extending above the anatomic level of the MCT over a period of five years from 2019 and 2023. All patients underwent surgical management.

View Article and Find Full Text PDF

Background And Importance: Superior oblique myokymia (SOM) is a rare, acquired aberration of the innervation of the superior oblique, resulting in episodic monocular contraction of the superior oblique muscle characterized by intermittent rotatory eye movement causing diplopia and oscillopsia. Several treatment modalities have been described to treat SOM, including medication and surgical interventions. There is a paucity of reports describing microvascular decompression (MVD) of the trochlear nerve near the root entry zone for the treatment of a neurovascular conflict.

View Article and Find Full Text PDF

Thyroid eye disease (TED) is a common extrathyroidal manifestation of hyperthyroidism, typically associated with Graves' disease (GD). This condition can cause severe functional limitations as well as significant aesthetic concerns. Treatment for TED patients aims to restore functionality and address aesthetic concerns.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!